Avience Biomedicals IPO
As of , the Avience Biomedicals IPO price band is ₹208 and the indicative grey-market premium (GMP) is +₹145 (69.71%). GMP is an unofficial, indicative figure that changes daily — not a target or recommendation.
About the Avience Biomedicals IPO
Avience Biomedicals is an SME IPO, proposed for listing on NSE SME. The issue has listed with a price band of ₹208 and a lot size of 600 shares. It was open from 18 June 2026 to 22 June 2026, with listing completed on 25 June 2026. The latest indicative grey-market premium (GMP) is +₹145 (69.71%) — an unofficial, speculative figure that is not a recommendation. All figures are indicative; confirm them against the official Red Herring Prospectus (RHP) before applying.
Avience Biomedicals IPO — FAQs
The Avience Biomedicals IPO price band is ₹208, with a lot size of 600 shares. Figures are indicative — confirm against the official RHP.
The grey-market premium (GMP) for Avience Biomedicals is around +₹145 (69.71%). GMP is an unofficial, indicative signal from the grey market and can change daily — it is not a recommendation.
The Avience Biomedicals IPO was open on 18 June 2026 and closed on 22 June 2026. Dates are subject to change per the official schedule.
All IPOs carry market risk. BuyUnlistedShares provides factual information and research, not investment advice or buy/sell recommendations. Read the RHP and assess suitability before applying.
Disclaimer: GMP and all figures are indicative and unofficial. BuyUnlistedShares provides information and research, not investment advice or buy/sell recommendations. Read the RHP before applying. Reviewed by Kanishk Dev Bangia (NISM-202300182946).